{"path":"images/Untitled 3 16.png","text":"Table 3Â¢ PROCHLORPERAZINES CHLORPROMAZINES PHENOTHIAZINES* Mechanism of action Central and peripheral dopamine antagonists Evidence for efficacy Superior to placebo for NVP (LOE-I) Recommended dose 5-10 mg TDS, max 30 mg/day Side effects Sedation, akathisia, anticholinergic effects, hypotension Rare: dystonias, tardive dyskinesia with chronic use Practice points Best reserved for evening dosing","libVersion":"0.2.4","langs":"eng"}